Stockreport

Cardiff Oncology to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Cardiff Oncology, Inc.  (CRDF) 
PDF SAN DIEGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel [Read more]